254. ポルフィリン症 Porphyria Clinical trials / Disease details
臨床試験数 : 70 / 薬物数 : 54 - (DrugBank : 19) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01550705 (ClinicalTrials.gov) | March 2012 | 5/3/2012 | Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria | Quantification of the Effects of Isoniazid Treatment on Erythrocyte and Plasma Protoporphyrin IX Concentration and Plasma Aminolevulinic Acid in Patients With Erythropoietic Protoporphyria | Erythropoietic Protoporphyria (EPP);X Linked Erythropoietic Protoporphyria | Drug: Isoniazid | University of Utah | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Icahn School of Medicine at Mount Sinai;University of Alabama at Birmingham;University of California, San Francisco;University of Texas | Terminated | 18 Years | N/A | All | 11 | N/A | United States |